CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes Long-Term All-Cause and Cause-Specific Mortality in Asymptomatic Patients With CAC ≥1,000: Results From the CAC Consortium Ten-Year All-Cause Death According to Completeness of Revascularization in Patients With Three-Vessel Disease or Left Main Coronary Artery Disease: Insights From the SYNTAX Extended Survival Study Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Incidence and Standardized Definitions of Mitral Valve Leaflet Adverse Events After Transcatheter Mitral Valve Repair: the EXPAND Study Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial

Consensus2020 Sep 1; 76(9): 1117–1145.

JOURNAL:J Am Coll Cardiol. Article Link

2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

SR Das, BM Everett, KK Birtcher et al. Keywords: T2DM; intensive glucose lowering; cardiovascular effect

Full Text PDF

网站资料更新中...